• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.

作者信息

Haegele K D, Schechter P J

出版信息

Clin Pharmacol Ther. 1986 Nov;40(5):581-6. doi: 10.1038/clpt.1986.227.

DOI:10.1038/clpt.1986.227
PMID:3769388
Abstract

Six healthy men received single oral doses of 1500 mg of vigabatrin [(R,S)-gamma-vinyl-GABA] and 750 mg of S(+)-gamma-vinyl-GABA on two occasions. Concentrations of the individual enantiomers were assayed by a stereoselective procedure based on combined GC/MS. At peak, concentrations of the R(-)-enantiomer exceeded concentrations of the S(+)-enantiomer, with an approximate ratio of 2:1. The mean terminal t1/2 ranged from 6 to 8 hours for both enantiomers. Mean urinary recovery of the S(+)-enantiomer was 49% after both doses and was 65% for the R(-)-enantiomer. Plasma concentration values obtained for the S(+)-enantiomer after a dose of the pure S(+)-enantiomer and an equivalent dose of the racemate showed good agreement for both the concentrations observed at any time point and the elimination characteristics, demonstrating bioequivalence. Renal clearance values for the S(+)-enantiomer are not affected by concomitant dosing with the pharmacologically inactive R(-)-enantiomer. No chiral inversion was detected after dosing with the pure S(+)-enantiomer.

摘要

相似文献

1
Kinetics of the enantiomers of vigabatrin after an oral dose of the racemate or the active S-enantiomer.
Clin Pharmacol Ther. 1986 Nov;40(5):581-6. doi: 10.1038/clpt.1986.227.
2
Vigabatrin. Clinical pharmacokinetics.
Clin Pharmacokinet. 1992 Oct;23(4):267-78. doi: 10.2165/00003088-199223040-00003.
3
Pharmacokinetics of the individual enantiomers of vigabatrin (gamma-vinyl GABA) in epileptic children.癫痫患儿中vigabatrin(γ-乙烯基氨基丁酸)各对映体的药代动力学
Br J Clin Pharmacol. 1990 Aug;30(2):253-7. doi: 10.1111/j.1365-2125.1990.tb03772.x.
4
Stereoselective uptake of the GABA-transaminase inhibitors gamma-vinyl GABA and gamma-acetylenic GABA into neurons and astrocytes.γ-乙烯基γ-氨基丁酸和γ-乙炔基γ-氨基丁酸这两种γ-氨基丁酸转氨酶抑制剂在神经元和星形胶质细胞中的立体选择性摄取。
Neurochem Res. 1986 Nov;11(11):1497-505. doi: 10.1007/BF00965769.
5
Pharmacokinetics of vigabatrin: implications of creatinine clearance.氨己烯酸的药代动力学:肌酐清除率的影响
Clin Pharmacol Ther. 1988 Nov;44(5):558-65. doi: 10.1038/clpt.1988.194.
6
Pharmacokinetics of the individual enantiomers of vigabatrin in neonates with uncontrolled seizures.氨己烯酸各对映体在癫痫未得到控制的新生儿中的药代动力学。
Br J Clin Pharmacol. 1996 Dec;42(6):779-81. doi: 10.1046/j.1365-2125.1996.00495.x.
7
Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.使用γ-氨基丁酸转氨酶抑制剂氨己烯酸对γ-氨基丁酸系统进行调控后的心理生理学和心理测量学研究。
Int J Psychophysiol. 1986 May;4(1):63-80. doi: 10.1016/0167-8760(86)90051-6.
8
Pharmacokinetics of the S(+) and R(-) enantiomers of vigabatrin during chronic dosing in a patient with renal failure.肾衰竭患者长期服用时,氨己烯酸S(+)和R(-)对映体的药代动力学。
Br J Clin Pharmacol. 1997 Aug;44(2):183-5. doi: 10.1046/j.1365-2125.1997.00636.x.
9
Clinical pharmacology of vigabatrin.氨己烯酸的临床药理学
Br J Clin Pharmacol. 1989;27 Suppl 1(Suppl 1):19S-22S. doi: 10.1111/j.1365-2125.1989.tb03456.x.
10
Binding of [3H]gamma-vinyl-GABA to GABA-transaminase in brain homogenates.
Life Sci. 1984 Feb 13;34(7):701-6. doi: 10.1016/0024-3205(84)90235-2.

引用本文的文献

1
Pharmacokinetics and tissue distribution of vigabatrin enantiomers in rats.氨己烯酸对映体在大鼠体内的药代动力学及组织分布
Saudi Pharm J. 2024 Feb;32(2):101934. doi: 10.1016/j.jsps.2023.101934. Epub 2023 Dec 23.
2
Inhibition of 4-aminobutyrate aminotransferase protects against injury-induced osteoarthritis in mice.抑制 4-氨基丁酸转氨酶可预防小鼠损伤诱导的骨关节炎。
JCI Insight. 2019 Sep 19;4(18):128568. doi: 10.1172/jci.insight.128568.
3
Preclinical tissue distribution and metabolic correlations of vigabatrin, an antiepileptic drug associated with potential use-limiting visual field defects.
抗癫痫药物氨己烯酸的临床前组织分布与代谢相关性研究及其对视功能限制相关潜在副作用的影响
Pharmacol Res Perspect. 2019 Jan 7;7(1):e00456. doi: 10.1002/prp2.456. eCollection 2019 Feb.
4
Pharmacokinetics and Drug Interaction of Antiepileptic Drugs in Children and Adolescents.抗癫痫药物在儿童和青少年中的药代动力学和药物相互作用。
Paediatr Drugs. 2018 Oct;20(5):429-453. doi: 10.1007/s40272-018-0302-4.
5
Design and Mechanism of GABA Aminotransferase Inactivators. Treatments for Epilepsies and Addictions.GABA 转氨酶失活剂的设计与机制。癫痫和成瘾的治疗方法。
Chem Rev. 2018 Apr 11;118(7):4037-4070. doi: 10.1021/acs.chemrev.8b00009. Epub 2018 Mar 23.
6
Monitoring vigabatrin in head injury patients by cerebral microdialysis: obtaining pharmacokinetic measurements in a neurocritical care setting.通过脑微透析监测头部受伤患者中的vigabatrin:在神经重症监护环境中获取药代动力学测量值。
Br J Clin Pharmacol. 2014 Nov;78(5):981-95. doi: 10.1111/bcp.12414.
7
Clinical management of seizures in newborns : diagnosis and treatment.新生儿惊厥的临床管理:诊断与治疗。
Paediatr Drugs. 2013 Feb;15(1):9-18. doi: 10.1007/s40272-012-0005-1.
8
Modern methods for analysis of antiepileptic drugs in the biological fluids for pharmacokinetics, bioequivalence and therapeutic drug monitoring.现代方法分析生物体液中的抗癫痫药物用于药代动力学、生物等效性和治疗药物监测。
Korean J Physiol Pharmacol. 2011 Apr;15(2):67-81. doi: 10.4196/kjpp.2011.15.2.67. Epub 2011 Apr 30.
9
Visual electrophysiological effect of a GABA transaminase blocker.一种γ-氨基丁酸转氨酶阻滞剂的视觉电生理效应
Doc Ophthalmol. 1998;97(2):179-88. doi: 10.1023/a:1002045223358.
10
Vigabatrin: placental transfer in vivo and excretion into breast milk of the enantiomers.氨己烯酸:对映体在体内的胎盘转运及向母乳中的排泄。
Br J Clin Pharmacol. 1998 Apr;45(4):409-11. doi: 10.1046/j.1365-2125.1998.t01-1-00693.x.